BEUDAMED
    FDA Adverse Event Injury Summary report: N

    AVANTA FLUID MANAGEMENT SYSTEM

    MDR report key: 23465581 · Received November 4, 2025

    Report

    Report Number
    2520313-2025-00027
    Event Type
    Injury
    Date Received
    November 4, 2025
    Date of Event
    October 27, 2025
    Report Date
    November 24, 2025
    Manufacturer
    BAYER MEDICAL CARE INC.
    Product Code
    DXT
    PMA / PMN Number
    K050456
    Adverse Event
    Yes
    Report Source
    Manufacturer report
    Reporter Location
    GM
    Reporter Occupation
    OTHER HEALTH CARE PROFESSIONAL
    Health Professional
    Yes

    Narratives

    Additional Manufacturer Narrative · 0

    A SYSTEM SERVICE CHECK OF MEDRAD® AVANTA FLUID MANAGEMENT INJECTION SYSTEM (SERIAL NUMBER (B)(6) WAS COMPLETED ON (B)(6) 2025 WHICH CONFIRMED THAT THE INJECTOR WAS OPERATING WITHIN BAYER SPECIFICATIONS. THE MULTI-PATIENT STERILE DISPOSABLE SET (MPAT) AND THE SINGLE-PATIENT STERILE DISPOSABLE SET (SPAT) WERE RETAINED BY THE SITE, BUT THE LOT NUMBERS WERE NOT PROVIDED BECAUSE THEY ARE UNKNOWN. SINCE THE SITE WILL NOT PROVIDE THE RETAINED SAMPLES AND THE LOT NUMBERS ARE UNKNOWN, BAYER CANNOT PERFORM ANY ADDITIONAL TESTING. THE MEDRAD® AVANTA FLUID MANAGEMENT SYSTEM OPERATION MANUAL CAUTIONS THE USER AS FOLLOWS: MINIMIZING AIR EMBOLIZATION RISKS: 1. WARNING: DO NOT INJECT AIR AIR EMBOLISM HAZARD: INJURY OR DEATH CAN RESULT. OBSERVE CHANGES IN FLUIDOTS® INDICATORS, FOR MEDRAD® SYRINGES. EXPEL AIR FROM SYRINGE/DISPOSABLES. - READ OPERATION MANUAL. 2. DO NOT CONNECT A PATIENT TO THE INJECTOR OR ATTEMPT AN INJECTION UNTIL ALL AIR HAS BEEN REMOVED FROM THE SYRINGE AND FLUID PATH. 3. EXPEL ALL AIR FROM THE SYRINGE, DRIP CHAMBERS, CONNECTORS, TUBINGS, TRANSDUCER, AND CATHETER BEFORE CONNECTING THE SYSTEM TO THE PATIENT. CAREFULLY READ THE INSTRUCTIONS FOR LOADING AND THE USE OF FLUIDOTS® INDICATORS (WHERE APPLICABLE) TO REDUCE THE CHANCE OF AIR EMBOLISM. 4. DISCONNECT THE PATIENT FROM THE AVANTA SINGLE-PATIENT DISPOSABLE SET (SPAT) IF A SYSTEM MALFUNCTION OCCURS. 5. VERIFY THAT THE FLUID PATH IS FREE OF AIR BEFORE ATTEMPTING AN INJECTION. ADDITIONAL CLINICAL APPLICATIONS TRAINING WAS PROVIDED ON NOVEMBER 11, 2025. THE SITE CONTINUES TO USE THE MEDRAD® AVANTA FLUID MANAGEMENT SYSTEM AFTER THE REPORTED EVENT. NO FURTHER ISSUES WERE REPORTED. THIS INFORMATION DOES NOT CONSTITUTE AN ADMISSION THAT THE DEVICE, THE COMPANY, OR ITS EMPLOYEES CAUSED OR CONTRIBUTED TO A REPORTABLE EVENT. NOTE: THE MANUFACTURE DATE FOR THIS DEVICE IS JANUARY 1, 2016, WHICH WAS PRIOR TO THE UDI IMPLEMENTATION DATE OF SEPTEMBER 24, 2016, FOR CLASS II DEVICES. AS SUCH, THIS EQUIPMENT WAS NOT YET REQUIRED TO BEAR UDI MARKING AND/OR REPORTED INTO THE GUDID DATABASE AT THE TIME.

    Additional Manufacturer Narrative · 0

    A SYSTEM SERVICE CHECK OF MEDRAD® AVANTA FLUID MANAGEMENT INJECTION SYSTEM (SERIAL NUMBER (B)(6)) WAS COMPLETED ON (B)(6) 2025 WHICH CONFIRMED THAT THE INJECTOR WAS OPERATING WITHIN BAYER SPECIFICATIONS. THIS INVESTIGATION REMAINS IN PROGRESS AS WE ARE AWAITING ADDITIONAL INFORMATION, INCLUDING THE DISPOSABLES INVOLVED. ONCE THE INVESTIGATION IS COMPLETED, A FOLLOW-UP REPORT WILL BE SUBMITTED. THIS INFORMATION DOES NOT CONSTITUTE AN ADMISSION THAT THE DEVICE, THE COMPANY, OR ITS EMPLOYEES CAUSED OR CONTRIBUTED TO A REPORTABLE EVENT. NOTE: THE MANUFACTURE DATE FOR THIS DEVICE IS JANUARY 1, 2016, WHICH WAS PRIOR TO THE UDI IMPLEMENTATION DATE OF SEPTEMBER 24, 2016, FOR CLASS II DEVICES. AS SUCH, THIS EQUIPMENT WAS NOT YET REQUIRED TO BEAR UDI MARKING AND/OR REPORTED INTO THE GUDID DATABASE AT THE TIME.

    Description of Event or Problem · 0

    BAYER MEDICAL CARE INC. WAS NOTIFIED OF AN ALLEGED AIR INJECTION THAT OCCURRED WHILE A PATIENT WAS CONNECTED TO A MEDRAD® AVANTA FLUID MANAGEMENT INJECTION SYSTEM (SERIAL NUMBER 201035). IT WAS REPORTED THAT THE PATIENT SUFFERED CARDIAC ARREST. AFTER SUCCESSFUL CARDIOPULMONARY RESUSCITATION (CPR), THE PATIENT WAS INTUBATED, AND EXTRACORPOREAL MEMBRANE OXYGENATION (ECMO) WAS IMPLEMENTED. THE PATIENT WAS REPORTED TO HAVE BEEN PLACED ON A VENTILATOR AND ADMITTED TO THE INTENSIVE CARE UNIT FOR FURTHER TREATMENT. THE CUSTOMER HAS STATED THAT NO FURTHER INFORMATION REGARDING THE INCIDENT WILL BE PROVIDED TO BAYER; THEREFORE, THE CURRENT STATUS OF THE PATIENT IS UNKNOWN.

    Description of Event or Problem · 0

    BAYER MEDICAL CARE INC. WAS NOTIFIED OF AN ALLEGED AIR INJECTION THAT OCCURRED WHILE A PATIENT WAS CONNECTED TO A MEDRAD® AVANTA FLUID MANAGEMENT INJECTION SYSTEM (SERIAL NUMBER (B)(6)). IT WAS REPORTED THAT THE PATIENT SUFFERED CARDIAC ARREST. AFTER SUCCESSFUL CARDIOPULMONARY RESUSCITATION (CPR), THE PATIENT WAS INTUBATED, AND EXTRACORPOREAL MEMBRANE OXYGENATION (ECMO) WAS IMPLEMENTED. THE PATIENT WAS SUBSEQUENTLY ADMITTED TO THE INTENSIVE CARE UNIT AND REMAINS VENTILATED.

    Devices

    Seq Brand Generic Product Code Manufacturer Model Lot UDI-DI
    1544394 AVANTA FLUID MANAGEMENT SYSTEM ANGIOGRAPHIC INJECTOR DXT BAYER MEDICAL CARE INC. 60726742

    Patients

    Seq Age Sex Outcome Treatment
    1 66 YR Male Other